NLRP3 and metabolic dysfunction-associated steatotic liver disease: A more reliable way to measure protein expression via Western blotting would be to confirm previous findings reported in the literature that the expression of NLRP3 and Caspase-1 was increased in patients with NAFLD (50, 51, 52).